Godavari Bioref.

INR
301.00
-11.7 (-3.74%)
BSENSE

Mar 27

BSE+NSE Vol: 3.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.83 lacs (-30.20%) Volume

Shareholding (Dec 2025)

FII

0.86%

Held by 4 FIIs

DII

1.14%

Held by 11 DIIs

Promoter

63.31%

Who are the top shareholders of the Godavari Bioref.?

06-Jun-2025

The top shareholders of Godavari Bioref. include Somaiya Agencies Private Limited with 17.3%, mutual funds holding 10.95% (led by HDFC Mutual Fund at 4.1%), and individual investors at 17.64%. There are also eight foreign institutional investors with a combined 0.97%, and no pledged promoter holdings are reported.

The top shareholders of Godavari Bioref. include a mix of promoters, mutual funds, and individual investors. The majority shareholder is Somaiya Agencies Private Limited, which holds 17.3% of the company. Additionally, mutual funds collectively hold 10.95% across six schemes, with HDFC Mutual Fund - HDFC Manufacturing Fund being the highest public shareholder at 4.1%. Individual investors account for 17.64% of the holdings. There are also eight foreign institutional investors (FIIs) holding a small portion of 0.97%. Notably, there are no pledged promoter holdings reported.

View full answer

Has Godavari Bioref. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Godavari Bioref.?

04-Jun-2025

Godavari Bioref.'s peers include Hind. Unilever, ITC, Nestle India, and others, with varying management and growth ratings. It has an average management risk and below-average capital structure, with its 1-year return not applicable.

Peers: The peers of Godavari Bioref. are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Lotus Chocolate, Vadilal Enterp., Mukka Proteins, Jindal Photo, and KSE.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Average management risk is present at Godavari Bioref., Lotus Chocolate, Vadilal Enterp., Mukka Proteins, Jindal Photo, and KSE. Growth ratings show Excellent growth at Lotus Chocolate, Good growth at Vadilal Enterp. and Mukka Proteins, while Below Average growth is noted at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, and Godavari Bioref. Capital Structure is rated Excellent for Hind. Unilever, ITC, Nestle India, Britannia Inds., and Godrej Consumer, while Below Average is noted for Godavari Bioref., Lotus Chocolate, Mukka Proteins, Jindal Photo, and KSE.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vadilal Enterp. at 215.15%, while the lowest is Godavari Bioref. with an N/A return. Godavari Bioref.'s 1-year return is not applicable, indicating it has not been reported. Additionally, peers with negative six-month returns include Lotus Chocolate, Mukka Proteins, and Godavari Bioref.

View full answer

Is Godavari Bioref. overvalued or undervalued?

09-Jun-2025

As of May 26, 2025, Godavari Bioref. is considered overvalued with a valuation grade of "attractive," reflected in its negative PE ratio of -53.80, high EV to EBITDA of 20.92, and low ROCE of 4.46%, especially when compared to peers like E.I.D.-Parry and Balrampur Chini Mills.

As of 26 May 2025, the valuation grade for Godavari Bioref. has moved from very attractive to attractive. The company appears to be overvalued based on its current financial metrics. Key ratios include a PE ratio of -53.80, an EV to EBITDA of 20.92, and a ROCE of 4.46%. In comparison, E.I.D.-Parry (India) Ltd. has a PE ratio of 27.55 and an EV to EBITDA of 5.63, while Balrampur Chini Mills Ltd. shows a PE of 28.14 and an EV to EBITDA of 21.19, indicating that Godavari Bioref. is trading at a significant premium relative to its peers.<BR><BR>The company's financials reflect challenges, particularly with a negative ROE of -5.49% and a PEG ratio of 0.00, suggesting limited growth prospects. While the stock has performed well recently, with a 1-month return of 74.99% compared to the Sensex's 3.80%, this may not be sustainable given the underlying valuation metrics. Overall, the analysis indicates that Godavari Bioref. is overvalued in the current market context.

View full answer

What does Godavari Bioref. do?

17-Jul-2025

Godavari Biorefineries Ltd is a small-cap FMCG company that specializes in biorefinery operations. As of March 2025, it reported net sales of ₹5,795 Cr and a net profit of ₹719 Cr.

Overview:<BR>Godavari Biorefineries Ltd operates in the FMCG industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Godavari Investment and Finance Corporation Limited' in 1956. It changed its name to 'Godavari Biorefineries Limited' in 2006. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 5,795 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 719 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,543 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 25 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.28 <BR>Return on Equity: -5.49% <BR>Price to Book: 3.00<BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

View full answer

How big is Godavari Bioref.?

24-Jul-2025

As of 24th July, Godavari Biorefineries Ltd has a market capitalization of 1,801.00 Cr, with recent net sales of 1,870.25 Cr and a net loss of 23.42 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Godavari Biorefineries Ltd has a market capitalization of 1,801.00 Cr and is classified as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest four quarters is 1,870.25 Cr, while the sum of Net Profit for the same period shows a loss of 23.42 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 500.68 Cr, and Total Assets amount to 1,991.66 Cr.

View full answer

Are Godavari Bioref. latest results good or bad?

08-Aug-2025

Godavari Biorefineries' latest results are unfavorable, with a significant decline in Profit Before Tax (PBT) to Rs -23.04 crore and Profit After Tax (PAT) to Rs -16.02 crore, alongside a 9.13% drop in net sales compared to the previous quarter. Overall, the company is facing considerable financial challenges.

The latest results for Godavari Biorefineries indicate a challenging financial situation. For the quarter ending June 2025, the company's Profit Before Tax (PBT) has significantly declined to Rs -23.04 crore, which is a drastic drop of 406.4% compared to the average PBT of Rs -4.55 crore over the previous four quarters. Similarly, the Profit After Tax (PAT) also fell sharply to Rs -16.02 crore, down 173.6% from an average of Rs -5.86 crore in the prior quarters.<BR><BR>Additionally, the company's net sales experienced a decrease of 9.13% compared to the previous quarter, which contrasts sharply with the impressive growth of 29.26% seen in March 2025. The standalone net profit showed a staggering decline of 123.74%, further highlighting the difficulties the company is facing.<BR><BR>Overall, these results suggest that Godavari Biorefineries is currently experiencing significant financial challenges, making the latest performance appear unfavorable.

View full answer

How has been the historical performance of Godavari Bioref.?

01-Dec-2025

Godavari Bioref. has faced significant fluctuations in financial performance, with net sales decreasing from 2,014.69 crore in March 2023 to 1,870.25 crore in March 2025, and profitability declining sharply, resulting in a profit after tax of -23.41 crore in March 2025. The company has struggled with rising expenditures and a notable drop in cash flow from operations.

Answer:<BR>The historical performance of Godavari Bioref. has shown significant fluctuations over the years, particularly in its net sales and profitability.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Godavari Bioref. reported net sales of 1,870.25 crore, an increase from 1,686.67 crore in March 2024 but a decrease from 2,014.69 crore in March 2023. The total operating income mirrored this trend, reaching 1,870.25 crore in March 2025. The company's total expenditure, excluding depreciation, rose to 1,766.60 crore in March 2025 from 1,553.13 crore in March 2024, leading to an operating profit (PBDIT) of 120.31 crore, down from 147.94 crore the previous year. This decline in profitability is reflected in the profit before tax, which fell to -1.54 crore in March 2025 from 12.45 crore in March 2024, resulting in a profit after tax of -23.41 crore compared to 12.30 crore in the prior year. The company's total assets decreased slightly to 1,955.09 crore in March 2025 from 1,991.50 crore in March 2024, while total liabilities also saw a decline to 1,955.09 crore from 1,991.50 crore. Cash flow from operating activities dropped significantly to 6.00 crore in March 2025 from 185.00 crore in March 2024, indicating challenges in generating cash from core operations. Overall, Godavari Bioref. has experienced a challenging financial environment, marked by declining profits and fluctuating sales.

View full answer

Is Godavari Bioref. technically bullish or bearish?

02-Dec-2025

As of December 1, 2025, the market trend has shifted to sideways with neutral indicators, as the weekly MACD and Bollinger Bands are bearish, while daily moving averages are mildly bullish but lack strong momentum.

As of 1 December 2025, the technical trend has changed from mildly bullish to sideways. The current stance is neutral, with weak indicators supporting this position. The weekly MACD is bearish, and Bollinger Bands also indicate a bearish trend. The daily moving averages are mildly bullish, but this is offset by the lack of signals from the RSI and the KST being mildly bearish. Additionally, Dow Theory shows no trend in both weekly and monthly time frames. Overall, the indicators suggest a lack of strong momentum in either direction.

View full answer

When is the next results date for Godavari Biorefineries Ltd?

05-Feb-2026

The next results date for Godavari Biorefineries Ltd is 13 February 2026.

The next results date for Godavari Biorefineries Ltd is scheduled for 13 February 2026.

View full answer

Should I buy, sell or hold Godavari Biorefineries Ltd?

10-Mar-2026

Why is Godavari Biorefineries Ltd falling/rising?

18-Mar-2026

As of 17-Mar, Godavari Biorefineries Ltd's stock price is rising to 310.00, reflecting a 5.89% increase. The stock has significantly outperformed the market over various time frames, despite a decline in investor participation.

As of 17-Mar, Godavari Biorefineries Ltd's stock price is rising, currently at 310.00, reflecting an increase of 17.25 or 5.89%. This upward movement is supported by several factors. Over the past week, the stock has gained 1.51%, while the benchmark Sensex has declined by 2.73%, indicating that Godavari Biorefineries is outperforming the market. In the last month, the stock has risen by 10.54%, contrasting with the Sensex's drop of 8.84%. Year-to-date, the stock has increased by 11.31%, while the Sensex has fallen by 10.74%. Over the past year, the stock has shown remarkable growth of 105.30%, significantly outperforming the Sensex's modest gain of 2.56%.<BR><BR>Today's performance highlights that the stock has outperformed its sector by 6.42% and has been on a consecutive gain streak for the last two days, accumulating a total return of 9.79% during this period. The stock reached an intraday high of Rs 311, reflecting a 6.23% increase. Additionally, Godavari Biorefineries is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically indicates a bullish trend.<BR><BR>However, it is worth noting that there has been a decline in investor participation, with delivery volume dropping by 37.55% compared to the 5-day average. Despite this, the stock remains liquid enough for trading, suggesting that the overall positive momentum is currently outweighing the negative factors.

View full answer

Why is Godavari Biorefineries Ltd falling/rising?

19-Mar-2026

As of 18-Mar, Godavari Biorefineries Ltd's stock price is at 324.35, reflecting a 5.22% increase. The stock has shown strong performance with significant gains over various time frames, outperforming the Sensex and indicating positive investor interest and technical indicators.

As of 18-Mar, Godavari Biorefineries Ltd's stock price is rising, currently at 324.35, reflecting a change of 16.1 or 5.22% increase. The stock has shown strong performance over various time frames, with a weekly increase of 9.69%, a monthly rise of 14.92%, and a year-to-date gain of 16.46%. Over the past year, the stock has surged by an impressive 104.96%, significantly outperforming the Sensex, which has only increased by 1.86% in the same period.<BR><BR>Today's performance indicates that the stock has outperformed its sector by 4.15% and has been on a consecutive gain streak for the last three days, accumulating a total return of 14.88% during this period. The stock reached an intraday high of Rs 342, marking a 10.95% increase, and has traded within a wide range of Rs 38.85, indicating active trading.<BR><BR>Additionally, Godavari Biorefineries Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive technical indicator. There has also been a notable increase in investor participation, with delivery volume rising by 16.01% compared to the 5-day average. The liquidity of the stock is sufficient for trading, as it represents 2% of the 5-day average traded value.<BR><BR>Overall, the combination of strong historical performance, positive technical indicators, and rising investor interest contributes to the upward movement of Godavari Biorefineries Ltd's stock price.

View full answer

Why is Godavari Biorefineries Ltd falling/rising?

20-Mar-2026

As of 19-Mar, Godavari Biorefineries Ltd's stock is experiencing a decline of 3.9% after three days of gains, indicating a trend reversal. Despite today's drop, the stock has performed well over the past week, and increased investor participation suggests ongoing interest.

As of 19-Mar, Godavari Biorefineries Ltd's stock price is currently falling, with a change of -12.65, representing a decline of 3.9%. This decline comes after a period of three consecutive days of gains, indicating a trend reversal. Despite the current drop, the stock has shown strong performance over the past week, with a gain of 7.85%, significantly outperforming the Sensex, which fell by 2.40% during the same period. <BR><BR>Today, the stock reached an intraday high of Rs 332.6 but also touched a low of Rs 311.15, reflecting volatility within the trading day. The weighted average price indicates that more volume was traded closer to the low price, suggesting selling pressure. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bullish trend, yet the current day's performance shows a clear underperformance against the sector by 4.14%.<BR><BR>Investor participation has increased, with a delivery volume of 5.01 lacs on March 18, which is up by 273.42% compared to the 5-day average. This rise in participation could indicate that investors are still interested in the stock despite today's decline. Overall, while Godavari Biorefineries Ltd has shown strong returns over longer periods, the immediate cause of the stock's fall today appears to be a combination of profit-taking after recent gains and current market volatility.

View full answer

Why is Godavari Biorefineries Ltd falling/rising?

21-Mar-2026

As of 20-Mar, Godavari Biorefineries Ltd's stock price is 316.05, reflecting a 1.2% increase and an 11.94% rise over the past week. Despite a significant profit decline of 357% over the past year, the stock's attractive valuation and positive price trends are driving investor interest.

As of 20-Mar, Godavari Biorefineries Ltd is experiencing a rise in its stock price, currently at 316.05, which reflects an increase of 3.75 or 1.2%. This upward movement can be attributed to several factors. Over the past week, the stock has shown a significant increase of 11.94%, contrasting with a slight decline of 0.04% in the Sensex. Additionally, the stock has outperformed the market over the past year, generating a remarkable return of 97.78%, compared to the market's return of only 0.76%.<BR><BR>Despite today's performance indicating that the stock underperformed its sector by 1.58%, it reached an intraday high of Rs 337.5, marking an increase of 8.07%. Furthermore, Godavari Biorefineries Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price movement. <BR><BR>However, it is important to note that the stock's profits have fallen significantly by 357% over the past year, which raises concerns about its long-term sustainability. Despite this, the stock's attractive valuation, indicated by a return on capital employed (ROCE) of 8 and a 1.8 enterprise value to capital employed ratio, may be contributing to investor interest, thereby supporting the current rise in stock price.

View full answer

Why is Godavari Biorefineries Ltd falling/rising?

24-Mar-2026

As of 23-Mar, Godavari Biorefineries Ltd's stock price is at 304.25, down 4.25%. This decline is influenced by sector underperformance, a significant drop in profits, and broader challenges in the sugar industry, despite a strong annual return of 86.83%.

As of 23-Mar, Godavari Biorefineries Ltd's stock price is currently at 304.25, reflecting a decrease of 13.5 points or 4.25%. This decline can be attributed to several factors. Firstly, the stock has underperformed its sector today by 1.13%, indicating weaker performance compared to its peers. Additionally, the stock reached an intraday low of Rs 300.55, which represents a drop of 5.41% from its previous levels.<BR><BR>Despite the recent decline, it is important to note that Godavari Biorefineries Ltd has shown strong performance over the past year, with an impressive return of 86.83%, significantly outperforming the broader market, which has seen negative returns of 5.47%. However, this high return comes alongside a concerning trend where the company's profits have fallen by 357%, suggesting that while the stock price has risen dramatically, the underlying financial health may be deteriorating.<BR><BR>Moreover, the overall sector, specifically the sugar industry, has also faced challenges, with a decline of 3.11%. This sector-wide downturn could be contributing to the stock's current price movement. Additionally, while there has been an increase in investor participation, as evidenced by a 64.25% rise in delivery volume, the stock's current trading position above its moving averages indicates some resilience, even amidst the recent price drop.<BR><BR>In summary, the combination of sector performance, profit declines, and current trading dynamics are influencing the stock's price movement, leading to its recent fall.

View full answer

Why is Godavari Biorefineries Ltd falling/rising?

25-Mar-2026

As of 24-Mar, Godavari Biorefineries Ltd's stock price is rising to 307.50, reflecting a 5.3 (1.75%) increase, supported by a 12.60% gain over the past month and an 82.49% return over the past year. Despite a positive opening and strong historical performance, there has been a decline in investor participation today.

As of 24-Mar, Godavari Biorefineries Ltd's stock price is rising, currently at 307.50, reflecting an increase of 5.3 (1.75%). This upward movement is supported by the stock's performance over the past month, where it has gained 12.60%, significantly outperforming the benchmark Sensex, which has declined by 9.92% during the same period. Additionally, the stock has shown remarkable growth over the past year, with a return of 82.49%, while the broader market has experienced a negative return of 5.02%.<BR><BR>Today's trading session began positively, with the stock opening up by 2.51% and reaching an intraday high of Rs 313.35, indicating strong investor interest. However, it is important to note that the stock has underperformed its sector by 0.27% today, and there has been a notable decline in investor participation, with delivery volume falling by 49.2% compared to the 5-day average. Despite this, the stock remains above its 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally positive trend.<BR><BR>Overall, the combination of strong historical returns, a positive opening today, and the stock's ability to outperform the market contributes to the current rise in Godavari Biorefineries Ltd's stock price.

View full answer

Why is Godavari Biorefineries Ltd falling/rising?

26-Mar-2026

As of 25-Mar, Godavari Biorefineries Ltd's stock price is at Rs 313.70, reflecting a 2.02% increase and a 13.29% gain over the past month. Despite a drop in investor participation, the stock shows strong upward momentum, trading above its moving averages, indicating a bullish outlook.

As of 25-Mar, Godavari Biorefineries Ltd's stock price is rising, currently at Rs 313.70, reflecting an increase of Rs 6.2 or 2.02%. The stock has shown a positive trend over the last two days, gaining 3.81% during this period. Additionally, it has performed well over the past month, with a return of 13.29%, significantly outperforming the Sensex, which declined by 8.51% in the same timeframe. <BR><BR>The stock is also trading above its moving averages for 5, 20, 50, 100, and 200 days, indicating a strong upward momentum. Furthermore, the sugar sector, in which Godavari operates, has seen a gain of 4.74%, contributing to the positive sentiment around the stock. However, it is important to note that the stock has underperformed its sector by 2.69% today, and there has been a significant drop in investor participation, with delivery volume falling by 61.16% compared to the 5-day average. Despite this decline in participation, the overall performance and recent gains suggest a bullish outlook for Godavari Biorefineries Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -24.69% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.11 times
  • The company has been able to generate a Return on Equity (avg) of 6.45% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 25

3

With ROCE of 8, it has a Attractive valuation with a 1.7 Enterprise value to Capital Employed

4

Falling Participation by Institutional Investors

5

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 1,571 Cr (Micro Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

20

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.63

stock-summary
Return on Equity

6.45%

stock-summary
Price to Book

2.21

Revenue and Profits:
Net Sales:
460 Cr
(Quarterly Results - Dec 2025)
Net Profit:
8 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.78%
0%
3.78%
6 Months
13.07%
0%
13.07%
1 Year
103.45%
0%
103.45%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Godavari Bioref. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Godavari Biorefineries Ltd Falls 3.42% Despite Technical Upgrade: 2 Key Factors Driving the Week

Announcements stock-summary

Closure of Trading Window

24-Mar-2026 | Source : BSE

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Credit Rating

17-Mar-2026 | Source : BSE

Credit Rating for the Companys Credit Facility and Fixed Deposit

Announcement Under Regulation 30 Of SEBI (LODR) Regulation

10-Mar-2026 | Source : BSE

The companys Japanese patent application title Use of Compounds for treating viral infection has been granted.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-3.70%
EBIT Growth (5y)
-24.69%
EBIT to Interest (avg)
1.33
Debt to EBITDA (avg)
5.00
Net Debt to Equity (avg)
0.63
Sales to Capital Employed (avg)
1.52
Tax Ratio
24.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.01%
ROCE (avg)
5.05%
ROE (avg)
6.45%

Valuation key factors

Factor
Value
P/E Ratio
28
Industry P/E
20
Price to Book Value
2.12
EV to EBIT
19.97
EV to EBITDA
13.01
EV to Capital Employed
1.69
EV to Sales
1.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.98%
ROE (Latest)
6.45%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 4 Schemes (10.02%)

FIIs

Held by 4 FIIs (0.86%)

Promoter with highest holding

Somaiya Agencies Pvt Ltd (17.3%)

Highest Public shareholder

Hdfc Mutual Fund - Hdfc Manufacturing Fund (4.1%)

Individual Investors Holdings

20.03%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 6.76% vs -19.22% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 119.84% vs -159.61% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "459.85",
          "val2": "430.75",
          "chgp": "6.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.07",
          "val2": "-7.93",
          "chgp": "643.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.21",
          "val2": "12.32",
          "chgp": "-17.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.88",
          "val2": "-26.66",
          "chgp": "70.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.25",
          "val2": "-41.59",
          "chgp": "119.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.37%",
          "val2": "-1.84%",
          "chgp": "11.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 14.29% vs 25.25% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 43.02% vs -10.73% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "963.99",
          "val2": "843.48",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.16",
          "val2": "-44.86",
          "chgp": "95.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.62",
          "val2": "39.86",
          "chgp": "-30.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-26.66",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-57.61",
          "val2": "-101.10",
          "chgp": "43.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.22%",
          "val2": "-5.32%",
          "chgp": "5.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 10.31% vs 20.47% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 48.23% vs -80.33% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,423.84",
          "val2": "1,290.75",
          "chgp": "10.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "40.91",
          "val2": "-8.76",
          "chgp": "567.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "37.83",
          "val2": "58.71",
          "chgp": "-35.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-34.54",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-49.36",
          "val2": "-95.34",
          "chgp": "48.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.87%",
          "val2": "-0.68%",
          "chgp": "3.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.88% vs -16.28% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -290.33% vs -37.37% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,870.25",
          "val2": "1,686.67",
          "chgp": "10.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "103.65",
          "val2": "133.54",
          "chgp": "-22.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "71.79",
          "val2": "75.56",
          "chgp": "-4.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-23.41",
          "val2": "12.30",
          "chgp": "-290.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.54%",
          "val2": "7.92%",
          "chgp": "-2.38%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
459.85
430.75
6.76%
Operating Profit (PBDIT) excl Other Income
43.07
-7.93
643.13%
Interest
10.21
12.32
-17.13%
Exceptional Items
-7.88
-26.66
70.44%
Consolidate Net Profit
8.25
-41.59
119.84%
Operating Profit Margin (Excl OI)
9.37%
-1.84%
11.21%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 6.76% vs -19.22% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 119.84% vs -159.61% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
963.99
843.48
14.29%
Operating Profit (PBDIT) excl Other Income
-2.16
-44.86
95.19%
Interest
27.62
39.86
-30.71%
Exceptional Items
-26.66
0.00
Consolidate Net Profit
-57.61
-101.10
43.02%
Operating Profit Margin (Excl OI)
-0.22%
-5.32%
5.10%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 14.29% vs 25.25% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 43.02% vs -10.73% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,423.84
1,290.75
10.31%
Operating Profit (PBDIT) excl Other Income
40.91
-8.76
567.01%
Interest
37.83
58.71
-35.56%
Exceptional Items
-34.54
0.00
Consolidate Net Profit
-49.36
-95.34
48.23%
Operating Profit Margin (Excl OI)
2.87%
-0.68%
3.55%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 10.31% vs 20.47% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 48.23% vs -80.33% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
1,870.25
1,686.67
10.88%
Operating Profit (PBDIT) excl Other Income
103.65
133.54
-22.38%
Interest
71.79
75.56
-4.99%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-23.41
12.30
-290.33%
Operating Profit Margin (Excl OI)
5.54%
7.92%
-2.38%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 10.88% vs -16.28% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -290.33% vs -37.37% in Mar 2024

stock-summaryCompany CV
About Godavari Biorefineries Ltd stock-summary
stock-summary
Godavari Biorefineries Ltd
Micro Cap
FMCG
Godavari Biorefineries Limited was originally incorporated as 'Godavari Investment and Finance Corporation Limited' in Mumbai on January 12, 1956. Subsequently, the name of the Company was changed as 'Godavari Biorefineries Limited' and a fresh Certificate of Incorporation consequent upon change in name was issued by Registrar of Companies on November 10, 2006.
Company Coordinates stock-summary
Icon
No Company Details Available